Preface

Pugliatti M Rosati G Cartoon H . The epidemiology of multiple sclerosis in Europe. Eur J Neurol 2006; 13: 700–722.

Kobelt G Berg J Lindgren P . Costs and quality of life of patients with multiple sclerosis in Europe.J Neurol Neurosurg Psychiatry 2006; 77: 918–926.

Defeating MS together: The European code of good practice in MS. Brussels: EMSP, 2014, pp. 1–52.

Ekestern E Lebhert G . Mortality from multiple sclerosis in Austria 1970-2001: Dynamics, trends and prospects. Eur J Neurol 2004; 11: 511–520.

Freedman MS Comi G De Stefano N . Moving toward earlier treatment of multiple sclerosis: Findings from a decade of clinical trials and implications for clinical practice. Mult Scler Relat Disord 2014; 3: 147–155.

Comi G . Disease-modifying treatments for progressive multiple sclerosis. Mult Scler 2013; 19: 1428–1436.

Ontaneda D Fox RJ . Progressive multiple sclerosis. Curr Opin Neurol 2015; 28: 237–243.

Salvetti M Landsman D Schwarz-Lam P . Progressive MS: From pathophysiology to drug discovery. Mult Scler 2015; 21: 1376–1384.

Fox RJ Thompson AJ Baker D . Setting a research agenda for progressive multiple sclerosis: The International Collaborative on Progressive MS. Mult Scler 2012; 18: 1534–1540.